Antagonists of PD-1 and PD-L1 in Cancer Treatment
Lipson, Evan J, Forde, Patrick M, Hammers, Hans-Joerg, Emens, Leisha A, Taube, Janis M, Topalian, Suzanne L
Published in Seminars in oncology (01.08.2015)
Published in Seminars in oncology (01.08.2015)
Get full text
Journal Article
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
Choueiri, Toni K, Dr, Escudier, Bernard, MD, Powles, Thomas, Prof, Tannir, Nizar M, Prof, Mainwaring, Paul N, MD, Rini, Brian I, Prof, Hammers, Hans J, MD, Donskov, Frede, MD, Roth, Bruce J, Prof, Peltola, Katriina, MD, Lee, Jae Lyun, Prof, Heng, Daniel Y C, MD, Schmidinger, Manuela, Prof, Agarwal, Neeraj, MD, Sternberg, Cora N, Prof, McDermott, David F, MD, Aftab, Dana T, PhD, Hessel, Colin, MS, Scheffold, Christian, MD, Schwab, Gisela, MD, Hutson, Thomas E, Prof, Pal, Sumanta, MD, Motzer, Robert J, Prof
Published in The lancet oncology (01.07.2016)
Published in The lancet oncology (01.07.2016)
Get full text
Journal Article
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
Motzer, Robert J, Rini, Brian I, McDermott, David F, Redman, Bruce G, Kuzel, Timothy M, Harrison, Michael R, Vaishampayan, Ulka N, Drabkin, Harry A, George, Saby, Logan, Theodore F, Margolin, Kim A, Plimack, Elizabeth R, Lambert, Alexandre M, Waxman, Ian M, Hammers, Hans J
Published in Journal of clinical oncology (01.05.2015)
Published in Journal of clinical oncology (01.05.2015)
Get full text
Journal Article
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial
Cella, David, Grünwald, Viktor, Escudier, Bernard, Hammers, Hans J, George, Saby, Nathan, Paul, Grimm, Marc-Oliver, Rini, Brian I, Doan, Justin, Ivanescu, Cristina, Paty, Jean, Mekan, Sabeen, Motzer, Robert J
Published in The lancet oncology (01.02.2019)
Published in The lancet oncology (01.02.2019)
Get full text
Journal Article
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, Robert J, Tannir, Nizar M, McDermott, David F, Arén Frontera, Osvaldo, Melichar, Bohuslav, Choueiri, Toni K, Plimack, Elizabeth R, Barthélémy, Philippe, Porta, Camillo, George, Saby, Powles, Thomas, Donskov, Frede, Neiman, Victoria, Kollmannsberger, Christian K, Salman, Pamela, Gurney, Howard, Hawkins, Robert, Ravaud, Alain, Grimm, Marc-Oliver, Bracarda, Sergio, Barrios, Carlos H, Tomita, Yoshihiko, Castellano, Daniel, Rini, Brian I, Chen, Allen C, Mekan, Sabeen, McHenry, M. Brent, Wind-Rotolo, Megan, Doan, Justin, Sharma, Padmanee, Hammers, Hans J, Escudier, Bernard
Published in The New England journal of medicine (05.04.2018)
Published in The New England journal of medicine (05.04.2018)
Get full text
Journal Article
Conditional survival and long‐term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma
Motzer, Robert J., McDermott, David F., Escudier, Bernard, Burotto, Mauricio, Choueiri, Toni K., Hammers, Hans J., Barthélémy, Philippe, Plimack, Elizabeth R., Porta, Camillo, George, Saby, Powles, Thomas, Donskov, Frede, Gurney, Howard, Kollmannsberger, Christian K., Grimm, Marc‐Oliver, Barrios, Carlos, Tomita, Yoshihiko, Castellano, Daniel, Grünwald, Viktor, Rini, Brian I., McHenry, M. Brent, Lee, Chung‐Wei, McCarthy, Jennifer, Ejzykowicz, Flavia, Tannir, Nizar M.
Published in Cancer (01.06.2022)
Published in Cancer (01.06.2022)
Get full text
Journal Article
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
Motzer, Robert J, Rini, Brian I, McDermott, David F, Arén Frontera, Osvaldo, Hammers, Hans J, Carducci, Michael A, Salman, Pamela, Escudier, Bernard, Beuselinck, Benoit, Amin, Asim, Porta, Camillo, George, Saby, Neiman, Victoria, Bracarda, Sergio, Tykodi, Scott S, Barthélémy, Philippe, Leibowitz-Amit, Raya, Plimack, Elizabeth R, Oosting, Sjoukje F, Redman, Bruce, Melichar, Bohuslav, Powles, Thomas, Nathan, Paul, Oudard, Stéphane, Pook, David, Choueiri, Toni K, Donskov, Frede, Grimm, Marc-Oliver, Gurney, Howard, Heng, Daniel Y C, Kollmannsberger, Christian K, Harrison, Michael R, Tomita, Yoshihiko, Duran, Ignacio, Grünwald, Viktor, McHenry, M Brent, Mekan, Sabeen, Tannir, Nizar M
Published in The lancet oncology (01.10.2019)
Published in The lancet oncology (01.10.2019)
Get full text
Journal Article
Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas
Zeng, Jing, MD, See, Alfred P., BS, Phallen, Jillian, BS, Jackson, Christopher M., BA, Belcaid, Zineb, MS, Ruzevick, Jacob, BS, Durham, Nicholas, BS, Meyer, Christian, MD, PhD, Harris, Timothy J., MD, PhD, Albesiano, Emilia, PhD, Pradilla, Gustavo, MD, Ford, Eric, PhD, Wong, John, PhD, Hammers, Hans-Joerg, MD, PhD, Mathios, Dimitris, MD, Tyler, Betty, BS, Brem, Henry, MD, Tran, Phuoc T., MD, PhD, Pardoll, Drew, MD, PhD, Drake, Charles G., MD, PhD, Lim, Michael, MD
Published in International journal of radiation oncology, biology, physics (01.06.2013)
Published in International journal of radiation oncology, biology, physics (01.06.2013)
Get full text
Journal Article
CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma
Escudier, Bernard, Sharma, Padmanee, McDermott, David F, George, Saby, Hammers, Hans J, Srinivas, Sandhya, Tykodi, Scott S, Sosman, Jeffrey A, Procopio, Giuseppe, Plimack, Elizabeth R, Castellano, Daniel, Gurney, Howard, Donskov, Frede, Peltola, Katriina, Wagstaff, John, Gauler, Thomas C, Ueda, Takeshi, Zhao, Huanyu, Waxman, Ian M, Motzer, Robert J
Published in European urology (01.12.2017)
Published in European urology (01.12.2017)
Get full text
Journal Article
Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
Chen, Linda, Douglass, Jacqueline, Kleinberg, Lawrence, Ye, Xiaobu, Marciscano, Ariel E., Forde, Patrick M., Brahmer, Julie, Lipson, Evan, Sharfman, William, Hammers, Hans, Naidoo, Jarushka, Bettegowda, Chetan, Lim, Michael, Redmond, Kristin J.
Published in International journal of radiation oncology, biology, physics (15.03.2018)
Published in International journal of radiation oncology, biology, physics (15.03.2018)
Get full text
Journal Article
Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
Hammers, Hans J, Plimack, Elizabeth R, Infante, Jeffrey R, Rini, Brian I, McDermott, David F, Lewis, Lionel D, Voss, Martin H, Sharma, Padmanee, Pal, Sumanta K, Razak, Albiruni R Abdul, Kollmannsberger, Christian, Heng, Daniel Y C, Spratlin, Jennifer, McHenry, M Brent, Amin, Asim
Published in Journal of clinical oncology (01.12.2017)
Published in Journal of clinical oncology (01.12.2017)
Get full text
Journal Article
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial
Motzer, Robert J., Escudier, Bernard, George, Saby, Hammers, Hans J., Srinivas, Sandhya, Tykodi, Scott S., Sosman, Jeffrey A., Plimack, Elizabeth R., Procopio, Giuseppe, McDermott, David F., Castellano, Daniel, Choueiri, Toni K., Donskov, Frede, Gurney, Howard, Oudard, Stéphane, Richardet, Martin, Peltola, Katriina, Alva, Ajjai S., Carducci, Michael, Wagstaff, John, Chevreau, Christine, Fukasawa, Satoshi, Tomita, Yoshihiko, Gauler, Thomas C., Kollmannsberger, Christian K., Schutz, Fabio A., Larkin, James, Cella, David, McHenry, M. Brent, Saggi, Shruti Shally, Tannir, Nizar M.
Published in Cancer (15.09.2020)
Published in Cancer (15.09.2020)
Get full text
Journal Article
Improved survival after cytoreductive nephrectomy for metastatic renal cell carcinoma in the contemporary immunotherapy era: An analysis of the National Cancer Database
Singla, Nirmish, Hutchinson, Ryan C., Ghandour, Rashed A., Freifeld, Yuval, Fang, Dong, Sagalowsky, Arthur I., Lotan, Yair, Bagrodia, Aditya, Margulis, Vitaly, Hammers, Hans J., Woldu, Solomon L.
Published in Urologic oncology (01.06.2020)
Published in Urologic oncology (01.06.2020)
Get full text
Journal Article
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, Robert J, Escudier, Bernard, McDermott, David F, George, Saby, Hammers, Hans J, Srinivas, Sandhya, Tykodi, Scott S, Sosman, Jeffrey A, Procopio, Giuseppe, Plimack, Elizabeth R, Castellano, Daniel, Choueiri, Toni K, Gurney, Howard, Donskov, Frede, Bono, Petri, Wagstaff, John, Gauler, Thomas C, Ueda, Takeshi, Tomita, Yoshihiko, Schutz, Fabio A, Kollmannsberger, Christian, Larkin, James, Ravaud, Alain, Simon, Jason S, Xu, Li-An, Waxman, Ian M, Sharma, Padmanee
Published in The New England journal of medicine (05.11.2015)
Published in The New England journal of medicine (05.11.2015)
Get full text
Journal Article
Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab
McDermott, David F, Drake, Charles G, Sznol, Mario, Choueiri, Toni K, Powderly, John D, Smith, David C, Brahmer, Julie R, Carvajal, Richard D, Hammers, Hans J, Puzanov, Igor, Hodi, F Stephen, Kluger, Harriet M, Topalian, Suzanne L, Pardoll, Drew M, Wigginton, Jon M, Kollia, Georgia D, Gupta, Ashok, McDonald, Dan, Sankar, Vindira, Sosman, Jeffrey A, Atkins, Michael B
Published in Journal of clinical oncology (20.06.2015)
Published in Journal of clinical oncology (20.06.2015)
Get full text
Journal Article
Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors
Gul, Anita, Stewart, Tyler F, Mantia, Charlene M, Shah, Neil J, Gatof, Emily Stern, Long, Ying, Allman, Kimberly D, Ornstein, Moshe C, Hammers, Hans J, McDermott, David F, Atkins, Michael B, Hurwitz, Michael, Rini, Brian I
Published in Journal of clinical oncology (20.09.2020)
Published in Journal of clinical oncology (20.09.2020)
Get full text
Journal Article
Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT
Rowe, Steven P., Gorin, Michael A., Hammers, Hans J., Som Javadi, M., Hawasli, Hazem, Szabo, Zsolt, Cho, Steve Y., Pomper, Martin G., Allaf, Mohamad E.
Published in Annals of nuclear medicine (01.12.2015)
Published in Annals of nuclear medicine (01.12.2015)
Get full text
Journal Article
Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists
Debnath, Sashi, Hao, Guiyang, Guan, Bing, Thapa, Pawan, Hao, Justin, Hammers, Hans, Sun, Xiankai
Published in International journal of molecular sciences (28.06.2022)
Published in International journal of molecular sciences (28.06.2022)
Get full text
Journal Article